This is a Randomized Study Comparing Two Doses of INT131 ( 3 mg and 1 mg) Administered Orally (PO) Daily (QD) Versus Placebo 1 Tablet PO QD in Subjects With Treatment-naïve RRMS for ≤ 3 Years
Clinical trial NCT02638038 · COMPLETED
Trial details
- NCT number
- NCT02638038
- Sponsor
- InteKrin Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-12-12
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.